Observational studyScientific reports2021

Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3-5.

Gustavo Lenci Marques et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.